Amaducci 1999.
Methods | multinational, multicentre, double blind, randomized, placebo controlled, parallel groups | |
Participants | SDAT mild to moderate; 24 patients received nicergoline, 24 placebo; age > 50 yr. | |
Interventions | Nicergoline or Placebo 30mg. twice a day (os) for 12 months | |
Outcomes | ADAScog, IADL, CGIC for efficacy; adverse events for safety | |
Notes | CGIC data were not available. ITT (LOCF) analysis is available |